269 related articles for article (PubMed ID: 37520990)
1. Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma.
Li XM; Liu SP; Li Y; Cai XM; Zhang SB; Xie ZF
Heliyon; 2023 Aug; 9(8):e18436. PubMed ID: 37520990
[TBL] [Abstract][Full Text] [Related]
2. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis based on the disulfidptosis-related genes identifies hub genes and immune infiltration for pancreatic adenocarcinoma.
Li Y; Chen MX; Li HT; Cai XM; Chen B; Xie ZF
Open Med (Wars); 2024; 19(1):20240906. PubMed ID: 38463521
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Yang L; Zhang W; Yan Y
Aging (Albany NY); 2023 Jul; 15(13):6135-6151. PubMed ID: 37399661
[TBL] [Abstract][Full Text] [Related]
5. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning.
Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D
Front Genet; 2023; 14():1193944. PubMed ID: 37456667
[No Abstract] [Full Text] [Related]
6. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma.
Liu JF; Huang L; Zhou XP; Li CR; Liu MF; Liang YH; Yu QH; Wu JR
Transl Cancer Res; 2024 Feb; 13(2):496-514. PubMed ID: 38482398
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel disulfidptosis-related signature for improving outcomes in hepatocellular carcinoma: Observational study.
Chen X; Liang Q; Zhou Y
Medicine (Baltimore); 2023 Oct; 102(40):e35423. PubMed ID: 37800779
[TBL] [Abstract][Full Text] [Related]
8. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile.
Wang T; Guo K; Zhang D; Wang H; Yin J; Cui H; Wu W
Int Immunopharmacol; 2023 Jul; 120():110368. PubMed ID: 37247499
[TBL] [Abstract][Full Text] [Related]
9. Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma.
Li XM; Liu SP; Liu DM; Li Y; Cai XM; Su Y; Xie ZF
Open Med (Wars); 2023; 18(1):20230825. PubMed ID: 37900961
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
Xiong Y; Kong X; Mei H; Wang J; Zhou S
Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
[TBL] [Abstract][Full Text] [Related]
12. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma.
Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L
Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525
[TBL] [Abstract][Full Text] [Related]
13. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy.
Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K
Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301
[TBL] [Abstract][Full Text] [Related]
14. Pancancer analysis reveals the role of disulfidptosis in predicting prognosis, immune infiltration and immunotherapy response in tumors.
Huang J; Xu Z; Chen D; Zhou C; Shen Y
Medicine (Baltimore); 2023 Dec; 102(52):e36830. PubMed ID: 38206694
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
[TBL] [Abstract][Full Text] [Related]
16. Machine learning identification and immune infiltration of disulfidptosis-related Alzheimer's disease molecular subtypes.
Zhu Y; Kong L; Han T; Yan Q; Liu J
Immun Inflamm Dis; 2023 Oct; 11(10):e1037. PubMed ID: 37904698
[TBL] [Abstract][Full Text] [Related]
17. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which
Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X
Front Immunol; 2023; 14():1205250. PubMed ID: 37426643
[TBL] [Abstract][Full Text] [Related]
18. Identification of disulfidptosis-related genes and analysis of immune infiltration characteristics in ischemic strokes.
Qin R; Huang L; Xu W; Qin Q; Liang X; Lai X; Huang X; Xie M; Chen L
Math Biosci Eng; 2023 Oct; 20(10):18939-18959. PubMed ID: 38052584
[TBL] [Abstract][Full Text] [Related]
19. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma.
Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease.
Fu M; Aihemaiti D; Fu H; Li N; Yuan Y; Ye M
J Inflamm Res; 2024; 17():3655-3670. PubMed ID: 38863903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
